Committee recommends Contracts of Insurance Bill moves forward

New Zealand’s Finance and Expenditure Committee has recommended that the Contracts of Insurance Bill move forward. After reviewing the bill, the committee proposed several key amendments:

  •  Insurers are allowed reasonable time to gather information when processing claims.

  • That dishonesty be treated as a lack of reasonable care rather than outright fraud.

  • That a power to create some regulation of the use of genetic tests in underwriting is included in the draft law.

Government officials anticipate the bill to be passed by the end of this year. Changes insurers will need to prepare for once the bill comes into force include reviewing existing contracts to ensure compliance with new consumer protection measures; preparing for potential regulations on the use of genetic data; and ensuring claims processing procedures meet the new ‘reasonable time’ requirements.

With regard to the power to regulate the use of genetic tests, the report states:

“We agree that this issue is important. Our view is that a cautionary approach to genetic testing is needed to avoid undue genetic discrimination. However, we also grappled with the question of how to address genetic testing in this bill. We considered the implications of different options, including a full legislative ban on “genetic discrimination”.

“Ultimately, we recommend inserting new regulation-making powers, in Part 3, new subpart 4A (clauses 86A, 86B, and 86C), that would enable the Governor-General, on a recommendation of the Minister, to prohibit or regulate the conduct of insurers in relation to genetic testing. Before recommending any regulations, we expect the Minister to conduct a full policy development and consultation process.”

More news:

Financial Advice NZ webinar 'Creating an equitable advice experience for couples' 25 September

Sharesies KiwiSaver members can now combine multiple base funds instead of having to choose only one for their KiwiSaver scheme

Consultation for the Government’s draft Suicide Prevention Action Plan 2025-2029 opens

From 1 October 2024, Keytruda will be funded for eligible people with certain cancers

Cervical screening self-test leads to increased screening among previously un- and under-screened women

Previous
Previous

Quality Product Research: Research Advisory Board – Central

Next
Next

How to generate a SOA report